Trending Now
Stocks In focus ahead as Wall Street grows hopeful of a...
The Invesco QQQ’s made new 12-month highs this morning and continue to climb. The QQQ’s are testing prior resistance of $347. It...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Arbutus Biopharma Corporation (NASDAQ:ABUS) Announce Positive AB-729 Single Dose Results In...
Arbutus Biopharma Corporation (NASDAQ:ABUS) has announced continued positive results for the ongoing phase 1a/1b clinical study with AB-729. AB-729 is the company’s GalNAc delivered...
MAKE IT MODERN
LATEST REVIEWS
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Winds Down Probuphine sales In The US...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced a strategic restructuring that will see its focus on product development of ProNeur®. This is in a bid...
MAKE IT MODERN
PERFORMANCE TRAINING
Moderna Inc (NASDAQ: MRNA) Demonstrates Improved Immune Response In Adolescents In Phase 2/3 Clinical...
Moderna Inc (NASDAQ: MRNA) demonstrated the safety of its COVID-19 vaccine in adolescents.
The company conducted a phase 2/3 clinical trial of its COVID-19 vaccine...
Axovant (NASDAQ:AXGT) Enters Strategic Development Partnership With Viralgen For AAV-gene Therapies
Axovant Gene Therapies Ltd (NASDAQ:AXGT) has signed of a strategic partnership with Viralgen one of the top Contract Development and Manufacturing Organisations (CDMO).
The partnership...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Releases Data Of AB-729 90 Mg Single-Dose In HBV
Arbutus Biopharma Corporation (NASDAQ:ABUS) has reported on-going positive data from its continuing Phase 1a/1b AB-729 clinical trial. AB-729 is the company’s novel GaINAc delivered...
Stocks Rise as OPEX week comes to an end (PERI, AMZN)
Futures are slightly red this morning seemingly on a gap down it seems in AAPL (-1.45%) although not seeing news on that. ...
The Coming Boost to Sports Media Stocks? (NKE, CHDN, BTDG, DKNG)
The Sports Media market is one of the most dynamic and chronically successful in the US economy and capital markets. But it has also...
MAKE IT MODERN
